FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

New strain of bird flu found; Panacea inks $35M vaccines deal;

Tools
  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

Vaccine Research

A new strain of bird flu has been discovered in Nigeria. Report

BN ImmunoTherapeutics has forged a scientific partnership with the National Cancer Institute in the United States. Under the Cooperative Research and Development Agreement, the NCI and BN ImmunoTherapeutics will jointly develop new therapeutic vaccines for prostate cancer. Release

The International AIDS Vaccine Initiative along with the ICMR and NACO is planning to conduct Phase I HIV prime-boost vaccine trials in Chennai and Pune. Report

Medicago will be presenting an update of its development of H5N1 vaccines generated from plant-made VLPs and unique technology platform at the Targeted Immunotherapeutics and Vaccine Summit. Release

Vaccine Market

Australia's CSL, which makes plasma products as well as vaccines, struck a deal to buy Talecris for $3.1 billion. Report

Panacea Biotech has signed a $35 million deal with Unicef to supply Pentavalent vaccines. Story

Alabama-based Vaxin, which is developing needle-free vaccines, appointed Bill Enright as its new CEO. Report

Federal investigators say that intense criticism of the country's anthrax vaccine prompted Bruce Ivins to launch deadly anthrax attacks against politicians and media figures. Article

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.